GRM1 and breast cancer: There was no correlation between mGluR1 and the overall survival of patients with breast cancer, but the expression of mGluR1 was positively correlated with the expression of the estrogen receptor (ER-positive) and progesterone receptor (PR-positive) in 60% of the sample (64).